| 英文名称 | 中文名称 | CAS | MF |
|
Pomalidomide-PEG2-N3
|
Pomalidomide-PEG2-N3
|
2267306-14-7
|
C19H20N6O7
|
|
Pomalidomide-PEG3-N3
|
Pomalidomide-PEG3-N3
|
2267306-15-8
|
C21H24N6O8
|
|
EGFR-IN-7 (compound 34)
|
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺
|
2267329-76-8
|
C32H41BrN9O2P
|
|
6-Quinoxalinamine, 5-(dimethylphosphinyl)-
|
(6-氨基喹喔啉-5-基)二甲基氧化膦
|
2267330-75-4
|
C10H12N3OP
|
|
4-(3'-bromo[1,1'-biphenyl]-3-yl)-2,6-diphridine
|
4-(3'-溴-[1,1'-联苯]-3-基)-2,6-二苯基吡啶
|
2267999-94-8
|
C29H20BrN
|
|
(4,8-Bis(5-(2-ethylhexyl)-4-octylthiophen-2-yl)benzo[1,2-b:4,5-b']dithiophene-2,6-diyl)bis(trimethylstannane)
|
(4,8-双(5-(2-乙基己基)-4-辛基噻吩-2-基)苯并[1,2-B:4,5-B']二噻吩-2,6-二基)双三甲基锡
|
2268032-19-3
|
C56H90S4Sn2
|
|
1-Boc-1-(2-bromobenzyl)hydrazine
|
1-Boc-1-(2-bromobenzyl)hydrazine
|
2268038-58-8
|
C12H17BrN2O2
|
|
4H-Dithieno[3,2-b:2',3'-d]pyrrole, 4-(2-octyldodecyl)-2,6-bis(trimethylstannyl)-
|
4H-Dithieno[3,2-b:2',3'-d]pyrrole, 4-(2-octyldodecyl)-2,6-bis(trimethylstannyl)-
|
2268696-17-7
|
C34H61NS2Sn2
|
|
URAT1 inhibitor 1
|
URAT1 INHIBITOR 1
|
2268720-62-1
|
C19H15Br2N5O2S2
|
|
Tofacitinib Impurity 85
|
Tofacitinib Impurity 85
|
2268720-86-9
|
C20H24ClN5
|
|
Crisaborole Impurity 16
|
Crisaborole Impurity 16
|
2268785-42-6
|
C14H10BNO3
|
|
Benzamide, N-[(1S)-2-amino-1-methyl-2-oxoethyl]-4-[(3-fluorophenyl)methoxy]-
|
沙芬酰胺杂质28
|
2268802-59-9
|
C17H17FN2O3
|
|
2,9-Di(tridecan-7-yl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,3aH,9H,12bH)-tetraone
|
2,9-Di(tridecan-7-yl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,3aH,9H,12bH)-tetraone
|
2268856-36-4
|
C50H64N2O4
|
|
Quinoxaline, 5,8-dibromo-6,7-difluoro-2-[(2-hexyldecyl)oxy]-
|
Quinoxaline, 5,8-dibromo-6,7-difluoro-2-[(2-hexyldecyl)oxy]-
|
2269476-12-0
|
C24H34Br2F2N2O
|
|
PTQ10
|
PTQ10
|
2269476-13-1
|
C34H54Br2F2N2OSSn2
|
|
p-F-PMABr
|
p-F-PMABr
|
2270172-94-4
|
C7H9BrFN
|
|
2,2'-Bioxazole, 4,4',5,5'-tetrahydro-4,4'-bis[(1S)-1-methylpropyl]-, (4R,4'R)-
|
(4R,4'R)-4,4'-二(S)-仲丁基)-4,4',5,5'-四氢-2,2'-联恶唑
|
2270178-41-9
|
C14H24N2O2
|
|
2,?2'-?Bioxazole, 4,?4',?5,?5'-?tetrahydro-?4,?4'-?bis(2-?methylpropyl)?-?, (4R,?4'R)?-
|
(4R,4'R)-4,4'-二异丁基-4,4',5,5'-四氢-2,2'-双恶唑
|
2270178-45-3
|
C14H24N2O2
|
|
Obeticholic acid 3-O-β-D-glucuronide
|
OBETICHOLIC ACID 3-O-Β-D-葡糖苷酸
|
2270232-93-2
|
C32H52O10
|
|
Poly[(thiophene)-alt-(6,7-difluoro-2-(2-hexyldecyloxy)quinoxaline)]
|
PTQ10
|
2270233-86-6
|
(C28H36F2N2OS)n
|
|
5,7-Di-tert-butyl-3-(2,6-diisopropylphenyl)benzo[d]oxazol-3-ium tetrafluoroborate
|
5,7-二叔丁基-3-(2,6-二异丙基苯基)苯并[D]恶唑-3-鎓四氟硼酸盐
|
2270864-45-2
|
C27H38BF4NO
|
|
4'-(1H-Imidazol-1-yl)[1,1'-biphenyl]-3,5-dicarboxylic acid
|
4'-(1H-Imidazol-1-yl)[1,1'-biphenyl]-3,5-dicarboxylic acid
|
2270877-19-3
|
C17H12N2O4
|
|
CHMFL-ABL-121
|
CHMFL-ABL-121
|
2270879-07-5
|
C30H31F3N6OS
|
|
1-(3-(difluoromethyl)isothiazol-5-yl)-3-(2-fluoro-5-(hydroxymethyl)pyridin-4-yl)urea
|
1-(3-(DIFLUOROMETHYL)ISOTHIAZOL-5-YL)-3-(2-FLUORO-5-(HYDROXYMETHYL)PYRIDIN-4-YL)UREA
|
2270879-17-7
|
C11H9F3N4O2S
|
|
J52-2Cl/PCIBZ/PBDT-Cl-BTZ
|
J52-2Cl/PCIBZ/PBDT-Cl-BTZ
|
2270904-38-4
|
|
|
tert-Butoxycarbonylamino-(4,4-difluorocyclohexyl)-acetic acid methyl ester
|
tert-Butoxycarbonylamino-(4,4-difluorocyclohexyl)-acetic acid methyl ester
|
2270904-94-2
|
C14H23F2NO4
|
|
[1,1'-Biphenyl]-3,4',5-tricarboxylic acid, 2',6'-dimethyl-
|
2',6'-二甲基-3,4',5-联苯三甲酸
|
2270937-70-5
|
C17H14O6
|
|
(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
(R)-3,3'-双(1-芘基)-1,1'-联萘酚磷酸酯
|
2270966-57-7
|
C52H29O4P
|
|
Palbociclib Impurity 38
|
帕布昔利布杂质38
|
2270982-31-3
|
C28H37N7O2
|
|
CL2 Linker
|
CL2 Linker
|
2270986-66-6
|
C68H103N11O22
|
|
E3 ligase Ligand-Linker Conjugates 50
|
E3 ligase Ligand-Linker Conjugates 50
|
2271036-44-1
|
C17H18N6O5
|
|
4-((2-(2-(2-azidoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
4-((2-(2-(2-azidoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
2271036-45-2
|
C19H22N6O6
|
|
Pomalidomide-NH-PEG3-azide
|
Pomalidomide-NH-PEG3-azide
|
2271036-46-3
|
C21H26N6O7
|
|
Pomalidomide-PEG4-azide
|
Pomalidomide-PEG4-azide
|
2271036-47-4
|
C23H30N6O8
|
|
MARK4 inhibitor 1
|
MARK4 inhibitor 1
|
2271081-58-2
|
C20H18N6O3
|
|
2-Cyclopenten-1-one, 4-hydroxy-2-(hydroxymethyl)-, (4S)-
|
(S)-4-羟基-2-(羟甲基)-2-环戊烯-1-酮
|
2271090-84-5
|
C6H8O3
|
|
CSF1R-IN-2
|
CSF1R-IN-2
|
2271119-26-5
|
C20H20FN7O2
|
|
Celecoxib Impurity 18
|
Celecoxib Impurity 18
|
2271123-54-5
|
C11H9F3O2
|
|
Benzamide, 3-chloro-N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
3-氯-N-甲基-5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯甲酰胺
|
2271133-59-4
|
C14H19BClNO3
|
|
IA-14069
|
IA-14069试剂
|
2271216-04-5
|
C20H15ClF2O4
|
|
DK78
|
2-氯-5-苯基-9,9-螺二芴
|
2271227-64-4
|
C31H19Cl
|
|
3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-
|
巴瑞克替尼杂质01
|
2271228-51-2
|
C16H19N7O3S
|
|
3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-
|
巴瑞替尼杂质 17
|
2271228-52-3
|
C16H18N6O4S
|
|
(R)-N-(2-benzoyl-4-chlorophenyl)-2-(3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]azepin-4-yl)acetamide 2,2,2-trifluoroacetate
|
(R)-N-(2-苯甲酰-4-氯苯基)-2-(3,5-二氢-4H-二萘并[2,1-C:1',2'-E] 氮杂卓-4-基) 乙酰胺2,2,2-三氟醋酸盐
|
2271234-11-6
|
C39H28ClF3N2O4
|
|
Dapagliflozin Impurity 14
|
达格列净杂质14
|
2271248-78-1
|
C21H25ClO6
|
|
Lifitegrast Impurity 8
|
立他司特杂质8
|
2271299-08-0
|
C29H24Cl2N2O7S
|
|
O1-tert-butyl O4-ethyl (3S,4S)-3-hydroxypiperidine-1,4-dicarboxylate
|
(3S,4S)-1-BOC-3-羟基哌啶-4-甲酸乙酯
|
2271349-56-3
|
C13H23NO5
|
|
UAMC-3203
|
UAMC-3203
|
2271358-64-4
|
C25H37N5O2S
|
|
UAMC-3203 hydrochloride
|
UAMC-3203 HYDROCHLORIDE
|
2271358-65-5
|
C25H38ClN5O2S
|
|
2,4,5,6-tetrahydro-1H-Cyclobut[f]inden-3-amine
|
2,4,5,6-四氢-1H-环丁[F]茚-3-胺
|
2271393-78-1
|
C11H13N
|
|
Oxazole, 2,2'-cyclohexylidenebis[4,5-dihydro-4-phenyl-, (4R,4'R)-
|
Oxazole, 2,2'-cyclohexylidenebis[4,5-dihydro-4-phenyl-, (4R,4'R)-
|
2271404-99-8
|
C24H26N2O2
|
|
HDACs/mTOR Inhibitor 1
|
HDACS/MTOR INHIBITOR 1
|
2271413-06-8
|
C28H38N8O5
|
|
L-Aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-, 1-(1,1-dimethylethyl) ester
|
FMOC-N-甲基-L-天冬氨酸-1-叔丁酯
|
2271413-88-6
|
C24H27NO6
|
|
1H-Indole-2-sulfonic acid, 6-hydroxy-1-methyl-
|
卡络磺钠杂质U
|
2271443-87-7
|
C9H9NO4S
|
|
Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 5-chloro-7-(methylamino)-, ethyl ester
|
5-氯-7-(甲基氨基)吡唑并[1,5-A]嘧啶-3-羧酸乙酯
|
2271470-64-3
|
C10H11ClN4O2
|
|
Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 5-chloro-7-[[(1,1-dimethylethoxy)carbonyl]methylamino]-
|
7-((叔丁氧羰基)(甲基)氨基)-5-氯吡唑并[1,5-A]嘧啶-3-羧酸
|
2271470-66-5
|
C13H15ClN4O4
|
|
Moxifloxacin Impurity 51
|
莫西沙星杂质51
|
2272024-58-3
|
C14H18N2O
|
|
(2S)-Boc-Pro(2-Ethyl)-OH
|
|
2272518-88-2
|
C12H21NO4
|
|
Cyclopropanepropanoic acid, β-cyclopropyl-α-[[(1,1-dimethylethoxy)carbonyl]amino]-
|
2-((叔丁氧基羰基)氨基)-3,3-二环丙基丙酸
|
2272861-72-8
|
C14H23NO4
|
|
Pyrazolo[1,5-a]pyrimidine-3-carboxamide, N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-
|
NDI-034858
|
2272904-53-5
|
C23H24N8O3
|
|
3H-Pyrazolo[3,4-d]pyrimidin-3-one, 6-[(2',3'-dihydro-2'-methylspiro[cyclopropane-1,4'(1'H)-isoquinolin]-7'-yl)amino]-1,2-dihydro-1-[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]-2-(2-propen-1-yl)-
|
JUN76288
|
2272976-28-8
|
C28H31N7O2
|
|
1-Boc-2-(3-bromobenzyl)-3-pyrrolidinone
|
1-BOC-2-(3-溴苄基)-3-吡咯烷酮
|
2274804-31-6
|
C16H20BrNO3
|
|
LUT-014
|
LUT-014
|
2274819-46-2
|
C27H19F3N8O
|
|
Loxoprofen
|
洛索洛芬杂质
|
2274853-20-0
|
C18H22O5
|
|
(4-chloro-2-(methoxymethoxy)phenyl)boronic acid
|
(4-氯-2-(甲氧基甲氧基)苯基)硼酸
|
2275572-12-6
|
C8H10BClO4
|
|
MDL-800
(MDL800)
|
2-[[(5-溴-4-氟-2-甲基苯基)氨基]磺酰基]-5-[[(3,5-二氯苯基)磺酰基]氨基]苯甲酸甲酯
|
2275619-53-7
|
C21H16BrCl2FN2O6S2
|
|
Benzoic acid, 2-[[(5-bromo-4-fluoro-2-methylphenyl)amino]sulfonyl]-5-[[(3,5-dichlorophenyl)sulfonyl]amino]-
|
化合物 MDL-801
|
2275619-55-9
|
C20H14BrCl2FN2O6S2
|
|
6,6',6",6"'-(9H-carbazole-1,3,6,8-tetrayl)tetrakis(2-naphthoic acid)
|
6,6',6",6"'-(9H-carbazole-1,3,6,8-tetrayl)tetrakis(2-naphthoic acid)
|
2275759-34-5
|
C56H33NO8
|
|
BAY 2666605
|
化合物BAY 2666605
|
2275774-60-0
|
C17H12F4N2O2
|
|
1,2-Pyrrolidinedicarboxylic acid, 2-ethyl-, 1-(1,1-dimethylethyl) ester, (2R)-
|
|
2276182-00-2
|
C12H21NO4
|
|
(2R)-2-[[(3R)-3-aminobutanoyl]amino]propanoic acid
|
HS-10352杂质D
|
2276229-34-4
|
C7H14N2O3
|
|
Alogliptin Related Compound 30
|
Alogliptin Related Compound 30
|
2276316-91-5
|
C10H16N4O2
|
|
2,4(1H,3H)-Pyrimidinedione, 6-[(3R)-3-amino-1-piperidinyl]-3-methyl-
|
阿格列汀杂质05
|
2276323-24-9
|
C10H16N4O2
|
|
1,2-Pyrrolidinedicarboxylic acid, 2-(3,3-dimethylbutyl)-, 1-(1,1-dimethylethyl) ester, (2S)-
|
|
2276356-17-1
|
C16H29NO4
|
|
L-Tyrosine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O,2-dimethyl-
|
(S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(4-甲氧基-2-甲基苯基)丙酸
|
2276402-03-8
|
C26H25NO5
|
|
Cyclohexanepropanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4,4-difluoro-, (αS)-
|
Fmoc-（S）-2-氨基-3-（4,4-二氟环己基）丙酸
|
2276607-04-4
|
C24H25F2NO4
|
|
Biotin-PEG11-CH2CH2N3
|
Biotin-PEG11-CH2CH2N3
|
2276672-04-7
|
C34H64N6O13S
|
|
Pitavastatin Impurity 18 Sodium Salt
|
匹伐他汀杂质18
|
2276678-27-2
|
C25H25FNNaO5
|
|
Propanamide, N-[(1R,2R)-2-[3-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-5,7-dihydro-5-oxo-6H-pyrrolo[3,4-b]pyridin-6-yl]cyclohexyl]-2,2,3,3,3-pentafluoro-
|
化合物 T-518
|
2276680-91-0
|
C19H16F7N5O3
|
|
(1R,3aS)-1-ethyl-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoline
|
2276801-81-9
|
2276801-81-9
|
C14H19N
|
|
1, 3, 5-Trimethyl-2, 4, 6-tris (4-cyanophenyl) benzene
|
1,3,5-三(4-氰基苯基)三甲苯
|
2278192-35-9
|
C30H21N3
|
|
Latanoprost Impurity 3
|
他氟前列素杂质8
|
2278245-92-2
|
C27H41BrO5
|
|
rac-(1R,2S)-2-(difluoromethyl)cyclopropane-1-carboxylic acid
|
REL-(1R,2S)-2-(二氟甲基)环丙烷-1-羧酸
|
2278284-80-1
|
C5H6F2O2
|
|
((3aR,4R,6R,6aR)-6-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,2,3a-trimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol
|
((3aR,4R,6R,6aR)-6-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,2,3a-trimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol
|
2278357-65-4
|
C15H18ClN3O4
|
|
(2S)-3-(2-bromo-5-fluorophenyl)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid
|
FMOC-L-(2-溴,5-氟)苯丙氨酸
|
2278366-87-1
|
C24H19BrFNO4
|
|
Linagliptin impurity KH-3
|
利格列汀杂质30
|
2279114-27-9
|
C30H37N7O6
|
|
Linagliptin impurity KH-2
|
N-(2-乙酰基苯基)-2-(8-溴-7-(丁-2-炔-1-基)-3-甲基-2,6-二氧代-2,3,6,7-四氢-1H--嘌呤-1-基)乙酰胺(利格列汀杂质)
|
2279114-31-5
|
C20H18BrN5O4
|
|
2-{[(tert-butoxy)carbonyl]amino}-2-(1,1-dioxo-1λ-thietan-3-yl)acetic acid
|
2-{[((叔丁氧基)羰基]氨基} -2-(1,1-二氧代-1ΛΑ-噻吨-3-基)乙酸
|
2279127-15-8
|
C10H17NO6S
|
|
2-([1,1'-biphenyl]-2-yl)-4-([1,1'-biphenyl]-4-yl)-6-chloro-1,3,5-triazine
|
2-([1,1'-biphenyl]-2-yl)-4-([1,1'-biphenyl]-4-yl)-6-chloro-1,3,5-triazine
|
2279137-61-8
|
C27H18ClN3
|
|
3-(4,4-difluorocyclohexyl)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid
|
2-(((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(4,4-二氟环己基)丙酸
|
2279733-97-8
|
C24H25F2NO4
|
|
TAMRA-PEG3-biotin
|
四甲基罗丹明-三聚乙二醇-生物素
|
2279944-59-9
|
C43H54N6O9S
|
|
PC SPDP-NHS carbonate ester
|
化合物 PC SPDP-NHS CARBONATE ESTER
|
2279944-61-3
|
C25H28N4O10S2
|
|
N,N'-DME-N-PEG2-Boc
|
N,N'-DME-N-PEG2-Boc
|
2279944-69-1
|
C15H32N2O4
|
|
Oleic-DBCO
|
油酸-二苯并环辛炔
|
2279951-78-7
|
C36H48N2O2
|
|
Oxazole, 2,2′-[2-phenyl-1-(phenylmethyl)ethylidene]bis[4,5-dihydro-4-(phenylmethyl)-, (4R,4′R)-
|
(4R,4'R)-2,2'-(1,3-二苯基丙烷-2,2-二基)双(4-苄基-4,5-二氢恶唑)
|
2279976-00-8
|
C35H34N2O2
|
|
Bobcat339
(Bobcat 339)
|
Bobcat339
(Bobcat 339)
|
2280037-51-4
|
C16H12ClN3O
|
|
Ezetimibe Impurity 34
|
依折麦布杂质34
|
2280081-69-6
|
C20H21NO4
|
|
Ethanone, 2,2'-iminobis[1-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
|
Ethanone, 2,2'-iminobis[1-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
|
2280085-84-7
|
C30H41N11O2
|
|
Real Thiol
|
Real Thiol
|
2280796-90-7
|
C20H17N3O7
|
|
RT-AM
|
RT-AM
|
2280796-94-1
|
C26H25N3O11
|